In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

We use cookies to optimise the design of this website and make continuous improvement. By continuing your visit, you consent to the use of cookies. Learn more

Discover the ESC Clinical Practice Guidelines on the topic

Aortic Diseases

Acute aortic diseases - how to diagnose and manage according to the new ESC Guidelines

ESC webinar

Add to calendar22/01/20150:00 22/01/20150:00 Europe/Paris Acute aortic diseases - how to diagnose and manage according to the new ESC Guidelines European Society of Cardiology DD/MM/YYYY
Diseases of the Aorta
Cardiovascular Surgery
Acute Cardiac Care

You will learn more on:

  • Role of imaging in aortic diseases
  • Diagnostic and therapeutic strategies in acute aortic syndromes
  • Heritable and genetic diseases of the aorta
  • Follow-up of chronic aortic diseases.


Raimund Erbel and Victor Aboyans

Watch part one of the recording

Watch part two of the recording

The ESC Webinars are designed to help you improve your daily practice!

The format includes a case based presentation, online assessment and live discussions with the 2 key opinion leaders who will give you some useful tips for your daily clinical practice.

Aortic Diseases: Diseases of the Aorta and Trauma to the Aorta and Heart
Document covering acute and chronic aortic diseases of the thoracic and abdominal aorta of the adult.

In addition to coronary and peripheral artery diseases, aortic diseases contribute to the wide spectrum of arterial diseases: aortic aneurysms, acute aortic syndromes (AAS) including aortic dissection (AD), intramural haematoma (IMH), penetrating atherosclerotic ulcer (PAU) and traumatic aortic injury (TAI), pseudoaneurysm, aortic rupture, atherosclerotic and inflammatory affections, as well as genetic diseases (e.g. Marfan syndrome) and congenital abnormalities including the coarctation of the aorta (CoA).



This programme is supported by Bayer HealthCare Pharmaceuticals, Bristol-Myers Squibb and Pfizer Alliance, Daiichi Sankyo Europe GmbH, Novartis Pharma AG and SERVIER in the form of unrestricted educational grants.
The scientific programme has not been influenced in any way by its sponsors.